NCT01824901View on ClinicalTrials.gov

Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

January 15, 2014

Primary Completion Date

July 9, 2014

Study Completion Date

April 30, 2015

Conditions
Recurrent Non-small Cell Lung CancerSquamous Cell Lung Cancer
Interventions
DRUG

docetaxel

Given IV

DRUG

AZD4547

Given PO

Trial Locations (5)

30322

Emory University, Atlanta

60611

Northwestern University, Chicago

75390

University of Texas Southwestern Medical Center, Dallas

21287-8936

Johns Hopkins University, Baltimore

02445-7648

Eastern Cooperative Oncology Group (ECOG) Research Base, Brookline

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

ECOG-ACRIN Cancer Research Group

NETWORK

NCT01824901 - Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter